Takeda Pharmaceutical Company (TAK) has released an update.
Takeda Pharmaceutical Company Limited has announced its slate of candidates for the Board of Directors to be presented at the 148th Ordinary General Meeting of Shareholders on June 26, 2024. Milano Furuta, poised to become the new CFO, will be proposed as a new board director, while current CFO Constantine Saroukos will retire from the Board upon his term’s expiration. The announcement includes a mix of both new and existing candidates, with tenures for non-Audit and Supervisory Committee directors set at one year, and for Audit and Supervisory Committee members at two years.
For further insights into TAK stock, check out TipRanks’ Stock Analysis page.
